Insmed Incorporated
-
Ticker
INSM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Bridgewater, New Jersey
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-infective directly to the site of serious lung infections.
REPORT RATINGS
4.8 / 5.0 (158)
Insmed Incorporated reports have an aggregate usefulness score of 4.8 based on 158 reviews.
Insmed Incorporated
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
View 2023 Responsibility Report
Older/Archived Annual Reports